FBT.US First Trust NYSE Arca Biotechnology Index Fund
- Total assets
- 3.07B
- Expense ratio
- 0.54%
- Dividend yield
- -
- 1-year return
- +33.43%
- Holdings
- 30
- Since
- 2006
Fund data as reported by the issuer, updated Nov 14, 2026. Total assets are in the fund's base currency.
What does FBT.US invest in?
- Mostly US stocks (93.0%)
- Largest sector: Healthcare (100.0%)
- Largest region: North America (98.4%)
- Top 3 holdings: 13.1% of the fund
Asset allocation
- US stocks 93.0%
- Non-US stocks 4.9%
- Cash 0.1%
Top holdings
- Genmab AS 4.54%
- ADMA Biologics Inc 4.37%
- Regeneron Pharmaceuticals Inc 4.19%
- Exelixis Inc 3.92%
- TG Therapeutics Inc 3.88%
First Trust NYSE Arca Biotechnology Index Fund performance
Sharpe ratio 1.23- This year
- +29.87%
- 1 year
- +33.43%
- 3 years
- +26.99%
- 5 years
- +11.21%
Volatility 20.2% over 1 year and 17.8% over 3 years. Moderate, similar to a broad stock index.
Total returns in the fund's currency as reported by the issuer; past returns do not predict future returns. Volatility is the yearly standard deviation of returns. Ask AI to explain these numbers
FBT.US price
Prices on the chart can differ slightly from the closing prices StockSummer shows.
About First Trust NYSE Arca Biotechnology Index Fund
The fund will normally invest at least 90% of its net assets (including investment borrowings) in the securities that comprise the index. The index is an equal-dollar weighted index designed to measure the performance of 30 leading biotechnology companies.
Full fund profileFirst Trust NYSE Arca Biotechnology Index Fund top holdings
39.5% of the fund| Holding | Sector | Country | Weight |
|---|---|---|---|
| Genmab AS GMAB.US | Healthcare | United States | 4.54% |
| ADMA Biologics Inc ADMA.US | Healthcare | United States | 4.37% |
| Regeneron Pharmaceuticals Inc REGN.US | Healthcare | United States | 4.19% |
| Exelixis Inc EXEL.US | Healthcare | United States | 3.92% |
| TG Therapeutics Inc TGTX.US | Healthcare | United States | 3.88% |
| Alkermes Plc ALKS.US | Healthcare | United States | 3.84% |
| argenx NV ADR ARGX.US | Healthcare | United States | 3.81% |
| Neurocrine Biosciences Inc NBIX.US | Healthcare | United States | 3.81% |
| BeiGene Ltd BGNE.US | Healthcare | United States | 3.65% |
| Amgen Inc AMGN.US | Healthcare | United States | 3.54% |
The 10 largest of 30 holdings.
FBT.US sector exposure
- Healthcare100.0%
Share of the stocks in the fund.
FBT.US regional exposure
- North America98.4%
- Europe Developed4.6%
Share of the stocks in the fund.
Company size
Average market cap 19.2B- Big cap19.2%
- Medium cap28.3%
- Small cap37.3%
- Micro cap11.3%
First Trust NYSE Arca Biotechnology Index Fund fund profile
- Fund name
- First Trust NYSE Arca Biotechnology Index Fund
- Ticker
- FBT.US
- Exchange
- USA Stocks
- Issuer
- First Trust
- Index tracked
- -
- Category
- Healthcare Equity
- Domicile
- United States
- Inception date
- Jun 19, 2006
- Trading currency
- USD
- Expense ratio
- 0.54%
- Annual turnover
- 0.3%
About First Trust NYSE Arca Biotechnology Index Fund
The fund will normally invest at least 90% of its net assets (including investment borrowings) in the securities that comprise the index. The index is an equal-dollar weighted index designed to measure the performance of 30 leading biotechnology companies.